The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia-Reference-Cited by-同舟云学术

The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia

Published:2023-11 Issue:5 Volume:165 Page:1168-1179.e6
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Khoshiwal Amir M.,Frei Nicola F.,Pouw Roos E.,Smolko Christian,Arora Meenakshi,Siegel Jennifer J.,Duits Lucas C.,Critchley-Thorne Rebecca J.^ORCID,Bergman Jacques J.G.H.M.,Goldblum John,Montgomery Elizabeth,Davison Jon,Singh Jagjit,Szymanski Jared,Perry Anthony,Seldenrijk Kees,Kate Fiebo ten,Offerhaus G. Johan A.,Drillenberg Paul,Jansen Casper,Leeuwis-Fedorovic Natalja,Chetty Runjan,Feakins Roger,Jansen Marnix,Chinyama Catherine,Cooper Edwin,Vaziri Reza,Baretton Gustavo,Tannapfel Andrea,Vieth Michael,Melcher Balint,Mesteri Ildiko,Müller Heiko,Wetzel Philipp,de Hertogh Gert,Hoorens Anne,Verschuere Stepanie,Tamsin An,Wetzels Kevin,Caillie Marie-Astrid van

Funder

Janssen Pharmaceuticals

Castle Biosciences Inc

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference30 articles.

1. Barrett’s esophagus and esophageal adenocarcinoma: how common are they really?;Thrift;Dig Dis Sci,2018

2. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int J Cancer,2019

3. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial;Phoa;JAMA,2014